Nature Biotechnology, USA.
Nat Biotechnol. 2009 Nov;27(11):986. doi: 10.1038/nbt1109-986.
Most drugs withdrawn from the market because of serious toxicities never make it back. But Biogen Idec succeeded in getting its multiple sclerosis (MS) drug Tysabri reintroduced in less than 16 months.
大多数因严重毒性而从市场撤出的药物都再也没有重新上市。但百健艾迪成功地使其多发性硬化症（MS）药物替昔珠单抗在不到 16 个月的时间内重新上市。
